Progesterone (P 4 ) inhibits small granulosa cell (GC) mitosis and large GC apoptosis. These actions are steroid specific and dose dependent and are inhibited by the progesterone receptor (PR) antagonist, RU-486. However, these cells do not express the nuclear PR but rather an ill-defined P 4 -binding protein (P 4 BP). This binding protein could function as a receptor and mediate P 4 's actions in GCs. Therefore, a series of studies was designed to characterize this P 4 BP. First, an antibody directed against the ligand-binding site of the nuclear PR was used in a Western blot analysis. This analysis revealed the presence of a 60-kDa P 4 BP within ovarian and GC lysates as well as within an ovarian membrane preparation. This protein was not observed in lysates of cells derived from the ovarian surface epithelium. In addition, this P 4 BP was immunoprecipitated by an antibody to the alpha, chain of the gamma aminobutyric acidA (GABA^) receptor, suggesting that the P 4 BP could be the ovarian GABAA receptor. Since activation of the rat ovarian GABAA receptor increases intracellular cAMP levels, GCs were cultured with control medium supplemented with either 8-bromo-cAMP (8-brcAMP), P4, or muscimol (a GABA agonist). Increases in cAMP were detected by monitoring the cAMP-dependent phosphorylation of cAMP response element-binding protein (CREB). Phosphorylated CREB was not observed in control or P 4 -treated cultures, but it was detected in the majority of both small and large GCs exposed to either 8-br-cAMP or muscimol. Since activation of the GABAA receptor with muscimol increases phosphorylated CREB but P 4 does not, this study indicates that P 4 does not activate the ovarian GABAA receptor. However, both bicuculline, a GABAA receptor antagonist, and the antibody to PR inhibited P 4 's ability to prevent both insulin-dependent mitosis and apoptosis. Collectively, these studies suggest that P4 mediates its antimitotic and anti-apoptotic effects through this 60-kDa P 4 BP, which has GABAA receptor-like properties and is localized within the surface membrane of GCs.
INTRODUCTION
The concept that progesterone (P 4 ) has an intraovarian site of action has been proposed for nearly 20 yr [1] . The data that support this concept come from both in vivo and in vitro experiments. In immature rats induced to ovulate with eCG and hCG, the 3-hydroxysteroid dehydrogenase inhibitor, epostane, reduces the number of ovulations [2] . Since epostane could not have altered gonadotropin levels, these results suggest a direct intraovarian site of action for P 4 . Similar studies have been also conducted in primates [3, 4] . In addition to having a role in ovulation, P 4 inhibits gonadotropin-induced follicular development in hypophysectomized hamsters [5] , suggesting that P 4 directly affects granulosa cells (GCs) of developing follicles.
Numerous studies have demonstrated P 4 's direct effects on GC function in vitro. For example, P 4 enhances the ability of cultured rat GCs to respond to FSH with increased production of cAMP [6] . Further, the synthetic progestin, R5020, increases FSH-and LH-induced P 4 secretion in vitro [7] . In contrast, progestins inhibit FSH-stimulated estrogen production by cultured rat GCs [7] [8] [9] [10] . Along with modulating steroidogenesis, P 4 suppresses insulin-dependent small GC mitosis [11, 12] and prevents large GCs from undergoing apoptosis [13, 14] . Both the anti-mitogenic and anti-apoptotic action of P 4 are dose dependent and steroid specific and are inhibited by the progesterone receptor (PR) antagonist, RU-486. In addition, P 4 's actions are not mimicked by dexamethasone [11] , indicating that they are not mediated by the ovarian glucocorticoid receptor.
In spite of this biological evidence, a direct role for P 4 in regulating rat GC function still remains controversial. This is primarily due to the inability to detect PR mRNA or protein within GCs until just prior to ovulation [15] [16] [17] [18] . Although PR mRNAs were not detected by Northern blot hybridization, in situ hybridization, or reverse transcriptionpolymerase chain reaction, the immature rat ovary expresses a protein that specifically binds P 4 [1, 19, 20] . This P 4 -binding protein (P 4 BP) is present within the cytosol/membrane fraction prepared from GCs of developing follicles. It is possible, then, that this P 4 BP could function as a membrane receptor for P 4 . If so, this putative membrane PR could possess the same P 4 -binding site as the nuclear PR but not share any other sequence homology. To test this hypothesis, an antibody, directed against the P 4 -binding site of the nuclear PR, was used to search for this putative membrane PR. The present studies identify a 60-kDa protein that is localized to the surface membrane of GCs and is involved in mediating P 4 's anti-mitogenic and anti-apoptotic action.
MATERIALS AND METHODS

Animals
Immature female Wistar rats (22 days of age) were obtained from Charles River Laboratory (Wilmington, MA) and housed under controlled conditions of temperature, humidity, and photoperiod (12L:12D; lights-on at 0700 h). On the day of the experiment, immature animals were 23-25 days of age. In some experiments, immature animals (23 days of age) were injected i.p. with 20 IU of eCG. All rats were cervically dislocated between 0930 and 1000 h. The ovaries were removed, and either ovarian lysates were prepared for Western blot analysis or GCs were isolated.
A spontaneously immortalized GC line (SIGCs) and a rat ovarian surface epithelial cell line (ROSE-179) were also used in these studies. Both cell lines were provided by Dr. Robert Burghardt (Texas A & M University, College Station, TX). These cells were cultured as previously de-scribed [21, 22] . Cell lysates were prepared from these cells and subsequently analyzed by Western blot.
Western Blot Analysis
Ovarian lysates were prepared from either fresh or frozen ovaries. GCs were isolated from the ovaries as described previously [23] , and SIGCs and ROSE-179 cells were harvested from culture dishes. The cells were then centrifuged at 200 X g for 10 min. Homogenization buffer (50 mM Tris, pH 7.4, 1 mM EDTA, 2 mM PMSF, 2 mM sodium vanadate) was added to the ovarian tissue or cell pellet, and the tissue/cells were homogenized in a glass homogenizer. The lysates were centrifuged at 13 000 g at 4C for 5 min, and the supernatant was removed and stored at -20 0 C.
Protein concentration for each lysate was determined by the Bradford method, and equal amounts of protein were loaded onto a 10% polyacrylamide gel and electrophoresed at 100 V. Proteins were transferred to nitrocellulose and then incubated with Tris-buffered saline with 0.1% Tween 20 and 5% dry milk for 1 h. The nitrocellulose was incubated with either an antibody to the PR (1:500, C-262; StressGen, Victoria, BC, Canada) or an antibody to the alpha, chain of the gamma aminobutyric acidA (GABAA) receptor (1:500; Boehringer-Mannheim, Indianapolis, IN). The nitrocellulose blot was washed twice with Tris-buffered saline and incubated with a 1:25 000 dilution of a peroxidase-labeled goat anti-mouse IgG (Kirkegaard and Perry, Gaithersburg, MD). The P 4 BP and GABAA receptors were detected by chemiluminescence using the detection system from Kirkegaard and Perry. An aliquot from each sample was also processed for Western blot analysis in the absence of a primary antibody. This served as a negative control. For quantitative analysis, the gels were scanned and analyzed using IP Lab Gel software (Signal Analytical, Vienna, VA). Density measurements were taken from both the Western blot and the negative control lane. The values from the negative control were subtracted from the values of the Western blot to yield a specific density value for each band.
A membrane fraction was also prepared from ovarian lysate as described by Khan-Dawood et al. [24] . For this preparation, ovarian lysate was centrifuged at 1000 x g for 10 min. The supernatant was removed and centrifuged at 100 000 x g for 60 min. The pellet was resuspended in 3-[N-morpholino]propanesulfonic acid buffer and centrifuged at 100 000 x g for 30 min. The supernatant contained the membrane fraction and was used for Western blot detection of P 4 BP.
To determine whether the P 4 BP has immunological characteristics of the GABAA receptor, an antibody to the alpha, chain of the GABAA receptor was used in an immunoprecipitation assay according to a protocol provided by Boehringer-Mannheim. Briefly, 100-150 iLg of ovarian lysate was mixed with 400 pxl of distilled water, 500 pl of doublestrength immunoprecipitation buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.2 mM sodium vanadate, 0.2 mM PMSF, 0.5% NP-40), and 10 g of GABAA receptor antibody. The mixture was vortexed and placed on ice for 1 h. Rabbit anti-mouse IgG (5 jig) was added and the mixture was vortexed. The incubation was continued for an additional 30 min. Finally, 50 il of a solution of 10% Protein A sepharose in 0.1 M phosphate buffer (pH 7.4) was added, and the mixture vortexed and incubated for 30 min in an ice bath with agitation. This mixture was then centrifuged at 13 000 x g for 5 min and washed three times with single-strength immunoprecipitation buffer. The pellet was resuspended in 20 pul of loading buffer, boiled for 5 min, centrifuged, and loaded onto a 10% polyacrylamide gel. The proteins were then transferred to nitrocellulose and probed with the PR antibody using the Western blot procedure described above.
GC Isolation and Culture
GCs were isolated according to the procedure of Lederer et al. [23] . Ovaries were placed in Medium 199 containing 0.2% BSA and 9.1 mM EGTA (pH 7.4). The follicles were punctured with fine needles and then incubated for 5 min at 37°C in 5% CO 2 in air. The ovaries were transferred to Medium 199 containing 0.2% BSA, 2.1 mM EGTA, and 0.5 mM sucrose (pH 7.4) and incubated for 10 min at 37°C in 5% CO 2 in air. The ovaries were transferred to fresh Medium 199 containing 0.2% BSA and pressed to release the GCs. This GC preparation was used in the various experiments described except for those studies involving mitosis or apoptosis. For these studies, small and large GC populations were isolated by Percoll gradient centrifugation as previously described [23] . Small GCs were collected from fractions 3 and 4, while large GCs were isolated from fractions 6 and 7. The GCs were washed and resuspended in RPMI-1640. Small GCs were plated in 35-mm dishes for mitosis studies, and large GCs were plated in Lab-tek 8-chamber slides (Nunc, Naperville, IL) for apoptosis experiments.
Preparation of Culture Medium and Reagents
RPMI-1640 without phenol red (Gibco Laboratories, Grand Island, NY) was used in all culture experiments. This medium was supplemented with penicillin (0.14 g/L), streptomycin (0.27 g/L), Hepes (4.76 g/L), BSA fraction V (2 g/L), sodium selenite (5 ng/ml), sodium bicarbonate (2.2 g/L), and transferrin (5 ,ug/ml). The pH was adjusted to 7.3, and the medium was filtered through a 0.2-jim filter. Insulin (5 ig/ml; Sigma Chemical Co., St. Louis, MO), P 4 (200 ng/ml; Sigma), PR antibody (10 jig/ml; C-262; StressGen), and bicuculline (10 M; Sigma) were added to cultures depending on the experimental design. P 4 was made as stock solution in ethanol at 1 mg/ml and then diluted in RPMI-1640 to the desired concentration.
Assessment of GC Mitosis and Apoptosis
Mitosis. Small GCs were plated at a density of 1.5-2 x 105 cells/ml of RPMI-1640 and incubated at 37°C in 5% CO 2 in air with RPMI-1640 supplemented with either 1) insulin, 2) insulin and P4, or 3) insulin, P4, and PR antibody. In some experiments, the effect of insulin and P 4 was assessed in the presence of IgG. This served as a control for the nonspecific effects of the PR antibody. After 2 h, the media were replaced in order to remove any nonattached GCs. The number of remaining GCs was counted within 8 different 160-jm 2 grids within the 35-mm dish [11, 12] . The grids were located at the ends of horizontal and vertical axes and at the center of each dish. After 24 h of culture, the number of GCs present in these same areas was determined. Cell proliferation was expressed as the percentage increase in cell number over 2-h control values. A similar study was conducted in which the ability of bicuculline to block P 4 's anti-mitotic action was assessed.
Apoptosis. Large GCs were plated in 8-chamber Lab-tek slides at plating density of 7 X 104 cell/400 jil. GCs were FIG. 1. Expression of a P 4 BP as detected by Western blot analysis. Lysates from immature ovary (Ovary), granulosa cells (GC) isolated from immature ovaries, or spontaneously immortalized granulosa cells (SIGC) were prepared. A) A P 4 BP of -60 kDa was detected in each lysate using an antibody directed against the P 4 -binding domain of the nuclear PR. B) Levels of this P 4 BP were slightly increased (-140%) after 24 h of eCG but then reduced to 80% of the initial value. In this and subsequent figures showing Western blots, a minus (-) sign represents a negative control for that specific sample. cultured in RPMI-1640 (control) supplemented with P 4 or P 4 plus PR antibody. To assess the nonspecific effects of the PR antibody, additional studies were conducted in which the effect of P 4 was determined in the presence of IgG. Cells were incubated for 24 h at 37°C in 5% CO 2 in air and then stained with hydroethidine (14 vig/ml of PBS; Polysciences, Warrington, PA) [13] . The percentage of apoptotic single cells was counted under epifluorescence as previously described [13] .
Detection of cAMP Response Element-Binding Protein (CREB) and Phosphorylated CREB
GCs were plated in 8-chamber Lab-tek slides at a density of 2-2.5 x 105 cells/400 L1 of RPMI-1640, which was supplemented with 10% FBS. After a 3-h incubation at 37°C in 5% CO 2 in air, the cells were washed three times with serum-free RPMI-1640 and treated with P 4 (200 ng/ml), 8-bromo-cAMP (8-br-cAMP; 100 g/ml), or the GABAA agonist muscimol (100 jiM; Sigma). The cells were then incubated for an additional 30 min. GCs were washed three times with PBS and fixed in 4% paraformaldehyde for 30 min at 4°C. The cells were stained for CREB and phosphorylated CREB using the PhosphoPlus CREB Antibody kit from New England BioLabs (Beverly, MA) and the HistoMark streptavidin-horseradish peroxidase system from Kirkegaard and Perry. The cells were mounted with glycerol and observed under brightfield optics. Cells expressing CREB or phosphorylated CREB were identified by a brown/orange stain. For each trial, a sample was stained in the absence of a primary antibody. This served as a negative control.
Statistical Analysis
All experiments were repeated two to three times. Those experiments that involved the assessment of mitosis or apoptosis were run in duplicate and replicated at least three times. These data were evaluated by an ANOVA followed by a Student-Newman-Keuls tests; p values 0.05 were considered to be significantly different.
RESULTS
Using an antibody directed against the P 4 -binding site of the nuclear PR, Western blot analysis revealed the presence Note that the 60-kDa P 4 BP is detected in this membrane preparation. B) To confirm that this 60-kDa protein binds P 4 , lysates from the same sample were electrophoresed, transferred to nitrocellulose, and then incubated with a buffered 5% dry-milk solution (Cont.) supplemented with progesterone (Prog.). The control was supplemented with 12% ethanol. The lanes were then processed for the detection of the P 4 BP. Notice that incubation with P 4 prior to Western blotting reduced the amount of detectable PBP by -80%.
of a 60-kDa protein in the ovaries and GCs of immature rats (Fig. 1A) . This protein was also detected within SIGCs (Fig. 1A) but not in ROSE-179 cells (data not shown). Treatment with eCG only slightly altered the expression of this protein, increasing the levels by approximately 140% at 24 h and decreasing the levels to 80% of initial values at 48 h after treatment (Fig. 1B) . The 60-kDa protein was also detected within the membrane fraction prepared from ovarian lysates (Fig. 2A) .
To determine whether this protein was capable of binding P 4 , an ovarian lysate was divided into equal aliquots. In one aliquot, the Western blot procedure was modified such that the dry-milk blocking solution was supplemented with P 4 (0.32 iM). The other aliquot was processed with the standard dry-milk blocking solution, which was supplemented with 12% ethanol. A comparison of the Western blots revealed that the P 4 supplement reduced the amount of P 4 BP detected by Western blot by -80% (Fig. 2B) . Further, supplementing the blocking solution with 0.32 ILM dexamethasone, estradiol-17, testosterone, a5o-pregnan3ot-ol-20-one, or 5-pregnane-3 3-21-diol-20-one did not impair the ability of the PR antibody to detect the 60-kDa protein (Fig. 3) . These data indicate that the 60-kDa protein binds P 4 in a steroid-specific manner.
The ability of this antibody to attenuate P 4 's anti-mitotic and anti-apoptotic action was also assessed. The mitotic studies confirm previous work demonstrating that insulin induces GC proliferation and P 4 blocks insulin's action FIG. 3. The P 4 -binding specificity of the 60-kDa P 4 BP. A single lysate was run using a preparative comb. The proteins were then transferred to a single sheet of nitrocellulose. The nitrocellulose sheet was cut into strips, and each strip was incubated with a dry-milk blocking solution that was supplemented with either 12% ethanol (EtOH), progesterone (Prog), 5a pregnane-33,21-diol-20-one (5a3[3), 5 pregnan-3a-ol-20-one (5o30o), dexamethasone (Dex), estradiol-1 7 (Est), or testosterone (Test). All steroids were used at a concentration of 0.32 jiM. A negative (Neg) control was also run in which the primary antibody was omitted. Note that only the Frog treatment reduced the amount of P 4 BP detected.
FIG. 4. The effect of P 4 and PR antibody on insulin-induced mitosis (A) and apoptosis (B)
. For these studies, GCs were separated into enriched populations of either small or large GCs using Percoll gradient centrifugation. The populations were approximately 80% pure. An increase in small GC mitosis was expressed as the percentage increase in cell number over the 2-h control value. To assess apoptosis, the large GC population was plated in 8-chamber Lab-tek slides in RPMI-1640 (control) supplemented with P 4 and/or the PR antibody. After 24 h, the percentage of apoptotic single cells was determined. In some mitosis and apoptosis experiments, both control and treatment groups were supplemented with the appropriate amounts of IgG. The presence of IgG did not alter the results of these experiments. [11, 12, 25] . The addition of the PR antibody completely neutralized P 4 's ability to block insulin-induced mitosis (Fig. 4A) . Similarly, the PR antibody attenuated P 4 's capacity to prevent large GCs from undergoing apoptosis (Fig. 4B) . P 4 's anti-mitotic and anti-apoptotic actions were observed in the presence of IgG (data not shown). In addition, the PR antibody did not affect the ability of basic fibroblast growth factor to prevent large GC apoptosis (data not shown).
In sperm, the effects of P 4 can be influenced by GABAA receptor antagonist, bicuculline [26] [27] [28] . Bicuculline also blocked P 4 's anti-mitotic and anti-apoptotic action in GCs (Fig. 5, A and B) . The alpha, chain of the GABAA receptor, a 50-kDa protein [29, 30] , was detected within the immature rat ovary by Western blot. In addition to this 50-kDa protein, the GABAA receptor antibody detected minor proteins with molecular masses of 60 and 69 kDa (Fig. 6A) . The GABAA receptor antibody immunoprecipitated a 60-kDa protein that was detected by the PR antibody (Fig. 6B) . This suggests that the 60-kDa protein, detected by the GA-BAA receptor antibody, is the P 4 -binding protein. The identity of the 69-kDa protein is unknown.
Given these observations, it is possible that P 4 mediates its action through the ovarian GABAA receptor. In the ova- FIG. 6 . Identification of a 60-kDa P 4 BP that can be immunoprecipitated with an antibody to the alpha, chain of the GABAA receptor. A) Western blot of an ovarian lysate probed with an antibody to the alpha, chain of the rat GABAA receptor. The major band in this blot identifies the 50-kDa alpha, chain of the GABAA receptor. Other minor bands were also detected, one of these being -60 kDa (marked by an arrow). This band can best be seen in the densitometry trace. B) When the ovarian lysate was immunoprecipitated (IP) with the antibody to the GABAA receptor and then probed with the antibody to the PR, a 60-kDa band was detected. This indicates that the 60-kDa P 4 BP shares some immunological characteristics with the GABAA receptor. The identity of the 69-kDa protein is not known.
ry, GABA increases the intracellular levels of cAMP [31] , which ultimately induces the phosphorylation of CREB [32] . To determine whether P 4 activates the ovarian GA-BAA receptor, the effect of various agents on the phosphorylation of CREB was assessed immunocytochemically. As shown in Figure 7E , both small and large cells expressed CREB. Phosphorylated CREB was not detected in small or large GCs under control culture conditions (Fig.  7A ). As expected, both 8-br-cAMP (Fig. 7B) and muscimol, a GABA agonist (Fig. 7D) , induced the phosphorylation of CREB in small and large GCs. However, P 4 did not induce the phosphorylation of CREB in either size of GC (Fig. 7C) . In addition, two P 4 metabolites that are known to activate the GABAA receptor, 5ax-pregnan-3oa-ol-20-one and 5ac-pregnane-3[-21-diol-20-one [33] , did not inhibit the detection of the 60-kDa P 4 -binding protein (Fig. 3) .
DISCUSSION
On the basis of previous ligand-binding studies, various investigators have predicted that GCs of immature and developing follicles would express a protein that specifically binds P 4 and functions as a PR [1, 19, 20] . By using an antibody directed against the P 4 -binding domain of the PR, the present study identifies such a protein. This protein has a molecular mass of 60 kDa and is expressed at relatively constant levels during eCG-induced follicular development. Further, this protein is expressed in GCs but not in cells derived from the rat ovarian surface epithelium, demonstrating ovarian cell-type specificity.
Since this 60-kDa protein was detected using an antibody directed against the P 4 -binding domain of the nuclear PR, it appears that it possesses the same P 4 -binding site as the A, B, and C forms of the nuclear PR [34] [35] [36] . However, this 60-kDa protein is not the A (-90 kDa) or B (-120 kDa) form of the PR [37] . It is also unlikely that this 60-kDa form is the C form of the PR, although the two proteins have similar molecular masses [34] [35] [36] . The C form of the PR is generally absent in PR-negative cells and requires high-salt conditions for nuclear extraction and subsequent FIG. 7 . The effect of P, 8-br-cAMP, and muscimol, a GABAA agonist, on the phosphorylation of CREB. GCs were plated in 8-chamber Lab-tek slides for 3 h in 5% CO 2 in air. Cells were then washed with PBS, and the following treatments were added: A) control, B) 8-br-cAMP, C) P,, or D) muscimol. The incubation continued for an additional 30 min. GCs were then washed and stained for CREB (E) or phosphorylated CREB (A-D) using a kit from New England BioLabs. (x400; reproduced at 87%). A negative control in which the primary antibody was omitted is shown in F.
detection by Western blot [34] [35] [36] . These characteristics are distinctly different from those of the 60-kDa protein described in the present studies. Further, while this 60-kDa P 4 BP shares the same immunologically identifiable P 4 -binding site as the PRs, it does not appear to be a member of the PR gene family, based on the observation that reverse transcription-polymerase chain reaction, using nucleotide primers that flank the P 4 -binding domain of the rat PR, fail to detect PR mRNA within the immature rat ovary [16] .
This 60-kDa protein may represent a novel protein that functions as a membrane PR, since it 1) binds P 4 , 2) has some immunological properties in common with both the nuclear PR and GABAA receptor, and 3) is involved in mediating P 4 's anti-mitotic and anti-apoptotic action. That this immunologically identified P 4 BP actually binds P 4 was demonstrated by supplementation of the dry-milk blocking solution with P 4 prior to Western blot analysis. This experiment showed that supplemental P 4 reduces the amount of P 4 BP detected by Western blot. This suppression of P 4 BP detection was observed only with P 4 and not with several other steroids, thereby demonstrating steroid specificity. It is assumed that the reduced ability of the PR antibody to detect the 60-kDa protein is due to the binding of the supplemental P 4 binding to a P 4 -binding domain within the 60-kDa protein. As a result, the PR antibody cannot bind to this site within the 60-kDa protein.
While the classic PRs are localized to the nucleus [36, 37] , the 60-kDa binding protein is localized to the surface membrane. The membrane localization of this 60-kDa protein was confirmed by the two different experimental approaches. First, the 60-kDa binding protein was detected in an ovarian membrane preparation. Although containing the membranes associated with cytoplasmic organelles, this preparation is enriched with plasma membranes. Second, P 4 's biological actions were inhibited by PR antibody. Since the PR antibody cannot enter nonpermeabilized GCs, it is likely that it interferes with P 4 's actions by binding to the P 4 -binding site of the 60-kDa protein that is apparently present on the extracellular surface of the plasma membrane.
Along with a limited immunological similarity to the nuclear PRs, this 60-kDa protein also has immunological characteristics of a GABAA receptor. The present studies show that this protein is immunoprecipitated by an antibody directed against the alphal chain of the GABAA receptor. In addition, the GABAA receptor antagonist, bicuculline, attenuates P 4 's anti-mitotic and anti-apoptotic action. However, P 4 does not mediate its action through the ovarian GABAA receptor, since the GABAA agonist muscimol, but not P 4 , stimulates the phosphorylation of CREB. Finally, neither 5ot-pregnan-3a-ol-20-one nor 5a-pregnane-3[3-21-diol-20-one interferes with P 4 binding to the 60-kDa P 4 BP. Since both of these P 4 metabolites bind to and activate the GABAA receptor [33] , the inability to compete with P 4 for the binding site within the 60-kDa P 4 BP suggests that the 60-kDa P 4 BP is not the GABAA receptor. Rather, it appears that the P 4 BP has some but not all the features of a GABAA receptor. P 4 likely mediates its action via this P 4 BP whose action can be modulated by the GABA antagonist, bicuculline. The mechanisms through which bicuculline interacts with the P 4 BP remain to be determined.
The signal transduction pathway that is activated by P 4 binding to this putative membrane receptor remains to be determined. In some cell types, P 4 increases intracellular levels of cAMP [38, 39] . In GCs, P 4 does not act in this manner, since it does not enhance the phosphorylation of CREB. P 4 has also been shown to stimulate a transient increase in intracellular calcium [2, 33, 40] . Although this cannot be ruled out, prolonged treatment with P 4 does not increase intracellular calcium levels within GCs but rather maintains intracellular calcium levels within a physiological range [13] . Similarly, it is not likely that P 4 activates the protein kinase C (PKC), since 1) P 4 inhibits GC mitosis [11] and 2) an activator of PKC, the phorbol ester 12-0-tetradecanoylphorbol 13-acetate, promotes GC mitosis [25] . Several other signal transduction pathways have been associated with P 4 's action in non-ovarian tissue. These signal transduction pathways include the suppression of adenylate cyclase, activation of a G protein-linked phosphatidylcholine-specific phospholipase C, induction of diacylglycerol and inositol 1,4,5-triphosphate, stimulation of tyrosine kinase activity, and regulation of chloride channels [2, 33, 41, 42] . The ability of P 4 to activate these pathways in GCs is presently being investigated.
Since multiple signal transduction pathways have been associated with P 4 's action, it is possible that there exist a [46] , using the same PR antibody that was used in the present studies, detected a 50-to 52-kDa P 4 BP in human sperm. None of these P 4 BPs have been cloned and sequenced. Thus, whether the 60-kDa P 4 BP expressed by GCs is similar to any of these other P 4 BPs cannot be determined. However, their existence is consistent with the hypothesis that there are multiple P 4 BPs that function as membrane PRs. These P 4 BPs are likely to be expressed in a tissue-and/or cell type-specific manner. If so, this 60-kDa protein may represent a GC-specific form of a membrane PR. Considerably more research is needed to validate this concept.
In summary, these studies support the concept that GCs express a 60-kDa P 4 BP that appears to function as a membrane receptor for P 4 and mediates P 4 's anti-mitotic and anti-apoptotic actions. Since GCs of immature and developing follicles do not express nuclear PRs, the existence of this protein is very important in that it provides a putative mechanism to account for P 4 's direct effects on these GCs. Further characterization of this protein should lead to a better understanding of P 4 's intraovarian role in regulating ovarian function.
